NYSE · CIK 0000877860
NHI NATIONAL HEALTH INVESTORS INC
Insider trading from SEC Form 4. Last filing Mar 5, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
4
with a Form 4 at this company
Signals
Open-market buys and sells at NATIONAL HEALTH INVESTORS INC, scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Congressional trades
2 trades in NHI disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | NHI National Health Investors, Inc. Common Stock | $1,001 to $15k | Jul 10, 2026 | 56 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | NHI National Health Investors, Inc. Common Stock | $1,001 to $15k | Jan 15, 2026 | 29 days after the trade |
Transactions
The last 7 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Gaines Kristin Sallee SVP/Chief Transaction Officer | AGrant or award Common Stock | +4,000 | $0.00 | $0 | 61,944 | Mar 5, 2025 |
| Mar 3, 2025 | COLDEN TRACY M J director | AGrant or award Stock Option (Right to Buy) 2025derivative | +10,000 | $0.00 | $0 | 10,000 | Mar 5, 2025 |
| Mar 3, 2025 | Gaines Kristin Sallee SVP/Chief Transaction Officer | AGrant or award Stock Option (Right to Buy) 2025derivative | +8,333 | $0.00 | $0 | 8,333 | Mar 5, 2025 |
| Mar 3, 2025 | Gaines Kristin Sallee SVP/Chief Transaction Officer | AGrant or award Stock Option (Right to Buy) 2025derivative | +8,333 | $0.00 | $0 | 8,333 | Mar 5, 2025 |
| Mar 3, 2025 | Jobe James R director | AGrant or award Stock Option (Right to Buy) 2025derivative | +10,000 | $0.00 | $0 | 10,000 | Mar 5, 2025 |
| Mar 3, 2025 | ADAMS ROBERT G director | AGrant or award Stock Option (Right to Buy) 2025derivative | +10,000 | $0.00 | $0 | 10,000 | Mar 5, 2025 |
| Mar 3, 2025 | Gaines Kristin Sallee SVP/Chief Transaction Officer | AGrant or award Stock Option (Right to Buy) 2025derivative | +8,334 | $0.00 | $0 | 8,334 | Mar 5, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- ADAMS ROBERT Gdirector
- COLDEN TRACY M Jofficer, director
- Gaines Kristin SalleeSVP/Chief Transaction Officer
- Jobe James Rdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.